CClinicalTrials.gg
RecruitingNCT07468734Updated Mar 19, 2026

Shock Wave Versus Traditional Physical Therapy for Adult Chronic Knee Osteoarthritis

An interventional study of Extracorporeal shock wave therapy and Exercise therapy program in Shock Wave, Traditional Physical Therapy and Chronic Knee Osteoarthritis, sponsored by German International University. Recruiting at 1 site in Egypt. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2026-03-19.

Sponsored by German International University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Mar 2026; still recruiting 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
40 Years and older
Sex
All
01

Study summary

This study aims to compare the effectiveness of extracorporeal shock wave therapy (ESWT) versus structured therapeutic exercise in patients with chronic knee osteoarthritis (KOA), with respect to pain reduction and improvement of knee function.

Read the detailed description

Knee osteoarthritis (KOA) is a highly prevalent chronic degenerative joint disease characterized by progressive cartilage loss, chronic pain, stiffness, functional disability, and reduced quality of life in adults, particularly the elderly.

Extracorporeal shock wave therapy (ESWT) has emerged as a non-invasive physical modality that delivers acoustic pressure waves to musculoskeletal tissues, stimulating biological responses such as enhanced microcirculation, anti-inflammatory cytokine modulation, neovascularization, cartilage and bone repair processes, and decreased pain transmission.

02

Conditions studied

  • Shock Wave
  • Traditional Physical Therapy
  • Chronic Knee Osteoarthritis
03

In context

Lead sponsor

German International University is the lead sponsor of 3 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adults ≥ 40 years with clinical and radiographic diagnosis of chronic knee osteoarthritis (KOA) (Kellgren-Lawrence grade II-III).
  • Both sexes.
  • Persistent knee pain ≥ 3 months.
  • Ability to provide consent and participate in interventions.

Exclusion criteria

Exclusion Criteria:

  • Prior knee surgery within last 6 months.
  • Intra-articular injections in the last 3 months.
  • Systemic inflammatory arthritis or other neurological conditions affecting gait.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    ESWT Group

    Patients will receive extracorporeal shock wave therapy.

    Other: Extracorporeal shock wave therapy

  • Active comparator
    Exercise Therapy Group

    Patients will undergo a structured exercise therapy program.

    Other: Exercise therapy program

Interventions

  • OtherExtracorporeal shock wave therapy

    Patients will receive extracorporeal shock wave therapy.

  • OtherExercise therapy program

    Patients will undergo a structured exercise therapy program.

06

What researchers measure

Primary outcomes

  1. Change in pain intensity

    Change in pain intensity will be assessed using the Visual Analogue Scale (VAS) which is a 10-cm horizontal line used to measure pain intensity, ranging from (0) "no pain" to (10) "worst imaginable pain".

    Time frame: 5-week after intervention

Secondary outcomes

  1. Stiffness assessment

    Stiffness will be assessed using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). WOMAC will be recorded at baseline, at the end of the intervention period, and during follow-up. Higher scores indicate greater symptom severity.

    Time frame: 5-week after intervention

  2. Assessment of physical function

    Physical function will be assessed using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). WOMAC will be recorded at baseline, at the end of the intervention period, and during follow-up. Higher scores indicate greater symptom severity.

    Time frame: 5-week after intervention

  3. Knee range of motion

    Knee range of motion (ROM) will be assessed.

    Time frame: 5-week after intervention

  4. Incidence of adverse events

    Incidence of adverse events will be recorded.

    Time frame: 5-week after intervention

07

Study locations

1 of 1 sites recruiting
  • German International University
    Cairo, 12613, Egypt
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07468734
Lead sponsor
German International University
Responsible party
Magdy Mohamed Aly Shabana (Associate Professor in Orthopedic, Physical Therapy, German International University) — Principal investigator
First posted
Mar 13, 2026
Start date
Mar 18, 2026
Primary completion
Nov 30, 2026 (estimated)
Completion
Nov 30, 2026 (estimated)
Last update
Mar 19, 2026

Study contacts

Magdy M Shabana, MD
Contact
magdy.shabana@giu-uni.de
00201006053332

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion